Embla is a digital provider of holistic obesity care, offering personal health coaching, AI-augmented healthcare staff, and individualized GLP-1a dosing. Members have lost over 15% of their initial weight, and some have tapered off medication, all while reducing GLP-1a usage by 60% compared to standard trials. A leader in Denmark, Embla is notable for its high-quality, real-world GLP-1a data. The recent UK expansion offers significant growth prospects.